Osaic Holdings’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-43
| Closed | -$543 | – | 7450 |
|
|
2024
Q2 | $543 | Sell |
43
-288
| -87% | -$3.64K | ﹤0.01% | 6764 |
|
|
2024
Q1 | $1.66K | Buy |
331
+73
| +28% | +$365 | ﹤0.01% | 6379 |
|
|
2023
Q4 | $1.85K | Sell |
258
-489
| -65% | -$3.51K | ﹤0.01% | 6433 |
|
|
2023
Q3 | $6.83K | Sell |
747
-150
| -17% | -$1.37K | ﹤0.01% | 6069 |
|
|
2023
Q2 | $18.9K | Sell |
897
-2,065
| -70% | -$43.6K | ﹤0.01% | 5579 |
|
|
2023
Q1 | $79.7K | Sell |
2,962
-1,846
| -38% | -$49.7K | ﹤0.01% | 4618 |
|
|
2022
Q4 | $169K | Sell |
4,808
-1,394
| -22% | -$49.1K | ﹤0.01% | 4002 |
|
|
2022
Q3 | $1.4M | Buy |
6,202
+1,420
| +30% | +$321K | ﹤0.01% | 1912 |
|
|
2022
Q2 | $904K | Buy |
4,782
+987
| +26% | +$187K | ﹤0.01% | 2378 |
|
|
2022
Q1 | $944K | Buy |
3,795
+507
| +15% | +$126K | ﹤0.01% | 2627 |
|
|
2021
Q4 | $512K | Sell |
3,288
-37
| -1% | -$5.76K | ﹤0.01% | 3039 |
|
|
2021
Q3 | $667K | Buy |
3,325
+333
| +11% | +$66.8K | ﹤0.01% | 2732 |
|
|
2021
Q2 | $764K | Buy |
2,992
+479
| +19% | +$122K | ﹤0.01% | 2587 |
|
|
2021
Q1 | $668K | Buy |
2,513
+650
| +35% | +$173K | ﹤0.01% | 2579 |
|
|
2020
Q4 | $687K | Buy |
1,863
+156
| +9% | +$57.5K | ﹤0.01% | 2372 |
|
|
2020
Q3 | $417K | Buy |
1,707
+1,694
| +13,031% | +$414K | ﹤0.01% | 2600 |
|
|
2020
Q2 | $4K | Buy |
+13
| New | +$4K | ﹤0.01% | 5535 |
|